A Study of 3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients. - Clinical Trial NCTNCT06849843

Business Opportunities for NCT06849843

Connect with principal investigators, study coordinators, and key decision makers for this PHASE2 trial studying investigational therapy for Type2 Diabetes.

Clinical Trial Information

Study Sponsor

Sponsor information available

Drug/Intervention

Study intervention details available

Therapeutic Area

Diabetes Mellitus, Diabetes Mellitus, Type 2

Study Phase

PHASE2

Study Status

RECRUITING

NCT Number

NCTNCT06849843

Find Contact Information

Access exclusive contact details for:

• Principal investigators and sub-investigators
• Study coordinators and research staff
• Site directors and facility contacts
• Sponsor representatives and CRO partners
• Business development professionals
• Clinical operations managers

Clinical Trial Locations

This study has 1 locations across China.

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

• Discover clinical trials before competitors
• Access exclusive contact information
• Track sponsor pipelines and opportunities
• Connect with decision makers directly
• Win more business partnerships